Skip to main content

#151528

Anti-von Willebrand Factor [RFF-VIII:R/1]

Cat. #151528

Anti-von Willebrand Factor [RFF-VIII:R/1]

Cat. #: 151528

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Von Willebrand factor (VWF)

Class: Monoclonal

Application: ELISA ; FACS ; IF ; Fn ; RIA ; WB

Reactivity: Primate

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Alison Goodall

Institute: University College London (UCL)

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-von Willebrand Factor [RFF-VIII:R/1]
  • Research fields: Stem cell biology;Tissue-specific biology
  • Clone: RFF-VIII:R/1
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Purpose: Marker
  • Conjugation: Unconjugated
  • Reactivity: Primate
  • Host: Mouse
  • Application: ELISA ; FACS ; IF ; Fn ; RIA ; WB
  • Description: Anti-Anti-Von Willebrand Factor [RFF-VIII:R/1] specifically binds to human factor VIII related antigen (VIII:RAg) in plasma and in vascular endothelial cells but has no reactivity with factor VIII procoagulant antigen (VIII:cAg). This antibody is a potent inhibitor of von Willebrand factor activity in that it can totally neutralise risocetin-induced aggregation of platelet rich plasma and inhibit platelet adhesion at high flow rates. RFF-VIII:R/2 can be used in a one-stage, fluid phase immuno...
  • Immunogen: Purified human Factor VIII-VWF complex
  • Isotype: IgG1 kappa
  • Myeloma used: P3/NS1/1-Ag4.1

Target Details

  • Target: Von Willebrand factor (VWF)
  • Tissue cell line specificity: Mouse
  • Target background: Anti-Anti-Von Willebrand Factor [RFF-VIII:R/1] specifically binds to human factor VIII related antigen (VIII:RAg) in plasma and in vascular endothelial cells but has no reactivity with factor VIII procoagulant antigen (VIII:cAg). This antibody is a potent inhibitor of von Willebrand factor activity in that it can totally neutralise risocetin-induced aggregation of platelet rich plasma and inhibit platelet adhesion at high flow rates. RFF-VIII:R/2 can be used in a one-stage, fluid phase immuno...

Applications

  • Application: ELISA ; FACS ; IF ; Fn ; RIA ; WB

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Dry ice

References

  • [Use of RFF-VIII:R/1 in the purification of FVIII]
  • Murdock et al. 1997. Thromb Haemost. 78(4):1272-7. PMID: 9364997.
  • von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use.
  • Takase et al. 1987. Br J Haematol. 66(4):497-502. PMID: 3117089.
  • Production of factor VIII deficient plasma by immunodepletion using three monoclonal antibodies.
  • McCraw et al. 1987. Thromb Res. 45(1):1...

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.